FDA Inspection 1019091 — Huntington Reproductive Center Medical Group

Huntington Reproductive Center Medical Group — FEI 3006501029

The FDA completed an inspection of Huntington Reproductive Center Medical Group on July 14, 2017 in Fullerton, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
July 14, 2017
Fiscal Year
2017
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Fullerton, CA (United States)